These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 16941499)
21. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Luiro K; Yliannala K; Ahtiainen L; Maunu H; Järvelä I; Kyttälä A; Jalanko A Hum Mol Genet; 2004 Dec; 13(23):3017-27. PubMed ID: 15471887 [TBL] [Abstract][Full Text] [Related]
22. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures. Ding SL; Tecedor L; Stein CS; Davidson BL Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858 [TBL] [Abstract][Full Text] [Related]
23. Astrocytes in juvenile neuronal ceroid lipofuscinosis (CLN3) display metabolic and calcium signaling abnormalities. Bosch ME; Kielian T J Neurochem; 2019 Mar; 148(5):612-624. PubMed ID: 29964296 [TBL] [Abstract][Full Text] [Related]
24. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3). Burkovetskaya M; Karpuk N; Kielian T Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098 [TBL] [Abstract][Full Text] [Related]
25. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease. Bensaoula T; Shibuya H; Katz ML; Smith JE; Johnson GS; John SK; Milam AH Ophthalmology; 2000 Sep; 107(9):1746-53. PubMed ID: 10964839 [TBL] [Abstract][Full Text] [Related]
26. Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Cotman SL; Vrbanac V; Lebel LA; Lee RL; Johnson KA; Donahue LR; Teed AM; Antonellis K; Bronson RT; Lerner TJ; MacDonald ME Hum Mol Genet; 2002 Oct; 11(22):2709-21. PubMed ID: 12374761 [TBL] [Abstract][Full Text] [Related]
27. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage. Dannhausen K; Möhle C; Langmann T Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155 [TBL] [Abstract][Full Text] [Related]
28. Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla. Stein CS; Yancey PH; Martins I; Sigmund RD; Stokes JB; Davidson BL Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1388-400. PubMed ID: 20219947 [TBL] [Abstract][Full Text] [Related]
30. Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons. Weimer JM; Custer AW; Benedict JW; Alexander NA; Kingsley E; Federoff HJ; Cooper JD; Pearce DA Neurobiol Dis; 2006 May; 22(2):284-93. PubMed ID: 16412658 [TBL] [Abstract][Full Text] [Related]
31. Immunochemical localization of the Batten disease (CLN3) protein in retina. Katz ML; Gao CL; Prabhakaram M; Shibuya H; Liu PC; Johnson GS Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2375-86. PubMed ID: 9344361 [TBL] [Abstract][Full Text] [Related]
32. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749 [TBL] [Abstract][Full Text] [Related]
33. Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease). Warnock A; Tan L; Li C; An Haack K; Narayan SB; Bennett MJ Biochem Biophys Res Commun; 2013 Jul; 436(4):645-9. PubMed ID: 23769828 [TBL] [Abstract][Full Text] [Related]
34. Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. Finn R; Kovács AD; Pearce DA Neurochem Int; 2011 May; 58(6):648-55. PubMed ID: 21315126 [TBL] [Abstract][Full Text] [Related]
35. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Järvelä I; Sainio M; Rantamäki T; Olkkonen VM; Carpén O; Peltonen L; Jalanko A Hum Mol Genet; 1998 Jan; 7(1):85-90. PubMed ID: 9384607 [TBL] [Abstract][Full Text] [Related]
36. Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis. Katz ML; Johnson GS; Tullis GE; Lei B Neurobiol Dis; 2008 Feb; 29(2):242-53. PubMed ID: 17962032 [TBL] [Abstract][Full Text] [Related]
37. Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice. Virmani T; Gupta P; Liu X; Kavalali ET; Hofmann SL Neurobiol Dis; 2005 Nov; 20(2):314-23. PubMed ID: 16242638 [TBL] [Abstract][Full Text] [Related]
38. Altered Cerebellar Short-Term Plasticity but No Change in Postsynaptic AMPA-Type Glutamate Receptors in a Mouse Model of Juvenile Batten Disease. Studniarczyk D; Needham EL; Mitchison HM; Farrant M; Cull-Candy SG eNeuro; 2018; 5(2):. PubMed ID: 29780879 [TBL] [Abstract][Full Text] [Related]
39. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292 [TBL] [Abstract][Full Text] [Related]
40. Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. Staropoli JF; Haliw L; Biswas S; Garrett L; Hölter SM; Becker L; Skosyrski S; Da Silva-Buttkus P; Calzada-Wack J; Neff F; Rathkolb B; Rozman J; Schrewe A; Adler T; Puk O; Sun M; Favor J; Racz I; Bekeredjian R; Busch DH; Graw J; Klingenspor M; Klopstock T; Wolf E; Wurst W; Zimmer A; Lopez E; Harati H; Hill E; Krause DS; Guide J; Dragileva E; Gale E; Wheeler VC; Boustany RM; Brown DE; Breton S; Ruether K; Gailus-Durner V; Fuchs H; de Angelis MH; Cotman SL PLoS One; 2012; 7(6):e38310. PubMed ID: 22701626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]